These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18033952)

  • 21. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of rapamycin treatment on cerebral ischemia: A systematic review and meta-analysis of animal model studies.
    Beard DJ; Hadley G; Thurley N; Howells DW; Sutherland BA; Buchan AM
    Int J Stroke; 2019 Feb; 14(2):137-145. PubMed ID: 30489210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Porównanie skuteczności piracetamu i dekstranu 40 tys. u chorych w podeszlym wieku z niedokrwiennym udarem mózgu].
    Kozubski W
    Wiad Lek; 1998; 51(7-8):321-5. PubMed ID: 9748886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical observations concerning piracetam treatment of patients after craniocerebral injury].
    Gościński I; Moskała M; Cichoński J; Polak J; Krupa M; Sliwonik S; Sondej T
    Przegl Lek; 1999; 56(2):119-20. PubMed ID: 10375942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meeting the challenge of treating epilepsy.
    Chadwick D; Wolf P
    Epileptic Disord; 2003 May; 5 Suppl 1():S7-8. PubMed ID: 12915335
    [No Abstract]   [Full Text] [Related]  

  • 27. Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update.
    McCann SK; Cramond F; Macleod MR; Sena ES
    Transl Stroke Res; 2016 Oct; 7(5):395-406. PubMed ID: 27526101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise reduces infarct volume and facilitates neurobehavioral recovery: results from a systematic review and meta-analysis of exercise in experimental models of focal ischemia.
    Egan KJ; Janssen H; Sena ES; Longley L; Speare S; Howells DW; Spratt NJ; Macleod MR; Mead GE; Bernhardt J
    Neurorehabil Neural Repair; 2014 Oct; 28(8):800-12. PubMed ID: 24553105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,026 experimental treatments in acute stroke.
    O'Collins VE; Macleod MR; Donnan GA; Horky LL; van der Worp BH; Howells DW
    Ann Neurol; 2006 Mar; 59(3):467-77. PubMed ID: 16453316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piracetam: a review of pharmacological properties and clinical uses.
    Winblad B
    CNS Drug Rev; 2005; 11(2):169-82. PubMed ID: 16007238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piracetam in the treatment of acute stroke.
    Orgogozo JM
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():25-32. PubMed ID: 10338105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia.
    Hanon E; Klitgaard H
    Seizure; 2001 Jun; 10(4):287-93. PubMed ID: 11466025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia].
    Tiurenkov IN; Bagmetov MN; Epishina VV
    Eksp Klin Farmakol; 2007; 70(2):24-9. PubMed ID: 17523446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Piracetam in severe cranio-cerebral injuries].
    Gościński I; Sliwonik S; Sondej T; Kwiatkowski S; Moskała M; Cichoński J; Wegrzyn D; Uhl H
    Neurol Neurochir Pol; 1998; 32(5):1189-97. PubMed ID: 10463232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke].
    Skorokhodov AP; Dudina AA; Kolesnikova EA; Koron AE; Kobantsev IuA; Sedova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():52-6. PubMed ID: 18193579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids in experimental stroke: a systematic review and meta-analysis.
    England TJ; Hind WH; Rasid NA; O'Sullivan SE
    J Cereb Blood Flow Metab; 2015 Mar; 35(3):348-58. PubMed ID: 25492113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
    Ikeda A; Shibasaki H; Tashiro K; Mizuno Y; Kimura J
    Mov Disord; 1996 Nov; 11(6):691-700. PubMed ID: 8914096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.
    Sawires H; Botrous O
    Eur J Pediatr; 2012 Jul; 171(7):1063-7. PubMed ID: 22302459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.